OBJECTIVE: To assess whether the risk of incidence of Alzheimer disease (AD) varies over time. The increase in numbers of people at the oldest ages in the population will bring an increase in the number of people with AD. Projections of the size of the increase assume the risk of AD is constant. METHODS:All persons age 65 or older in a biracial, geographically defined area were invited to participate in a home interview every 3 years. From the approximately 10,000 participants, stratified random samples were selected for detailed clinical evaluation. At each cycle, individuals determined free of AD in a previous cycle, either by examination or by high score on cognitive function tests, were sampled in the subsequent cycle for evaluation for incident AD. The evaluations for disease were structured and uniform across time. These analyses include 1,695 subjects evaluated for incident disease from 1997 through 2008. RESULTS: AD developed in 360 participants. Change over time in risk of incident disease was assessed in logistic regression analyses including evaluation date and controlling for age, gender, education, race, interval from disease-free designation to evaluation for incident disease, and sample design. The time variable (in years) was not significant (odds ratio = 0.970, 95% confidence interval = 0.902 to 1.044). CONCLUSIONS: The null relation of evaluation date to disease incidence suggests no recent change in risk of AD over time, and supports this assumption for projections of AD.
RCT Entities:
OBJECTIVE: To assess whether the risk of incidence of Alzheimer disease (AD) varies over time. The increase in numbers of people at the oldest ages in the population will bring an increase in the number of people with AD. Projections of the size of the increase assume the risk of AD is constant. METHODS: All persons age 65 or older in a biracial, geographically defined area were invited to participate in a home interview every 3 years. From the approximately 10,000 participants, stratified random samples were selected for detailed clinical evaluation. At each cycle, individuals determined free of AD in a previous cycle, either by examination or by high score on cognitive function tests, were sampled in the subsequent cycle for evaluation for incident AD. The evaluations for disease were structured and uniform across time. These analyses include 1,695 subjects evaluated for incident disease from 1997 through 2008. RESULTS:AD developed in 360 participants. Change over time in risk of incident disease was assessed in logistic regression analyses including evaluation date and controlling for age, gender, education, race, interval from disease-free designation to evaluation for incident disease, and sample design. The time variable (in years) was not significant (odds ratio = 0.970, 95% confidence interval = 0.902 to 1.044). CONCLUSIONS: The null relation of evaluation date to disease incidence suggests no recent change in risk of AD over time, and supports this assumption for projections of AD.
Authors: Denis A Evans; David A Bennett; Robert S Wilson; Julia L Bienias; Martha Clare Morris; Paul A Scherr; Liesi E Hebert; Neelum Aggarwal; Laurel A Beckett; Rajiv Joglekar; Elizabeth Berry-Kravis; Julie Schneider Journal: Arch Neurol Date: 2003-02
Authors: Julia L Bienias; Laurel A Beckett; David A Bennett; Robert S Wilson; Denis A Evans Journal: J Alzheimers Dis Date: 2003-10 Impact factor: 4.472
Authors: Sujuan Gao; Heather N Burney; Chris M Callahan; Christianna E Purnell; Hugh C Hendrie Journal: J Am Geriatr Soc Date: 2019-06-20 Impact factor: 5.562
Authors: David A Bennett; Steven E Arnold; Michael J Valenzuela; Carol Brayne; Julie A Schneider Journal: Acta Neuropathol Date: 2013-12-20 Impact factor: 17.088
Authors: Carey E Gleason; Derek Norton; Megan Zuelsdorff; Susan F Benton; Mary F Wyman; Naomi Nystrom; Nickolas Lambrou; Hector Salazar; Rebecca L Koscik; Erin Jonaitis; Fabu Carter; Brieanna Harris; Alexander Gee; Nathaniel Chin; Frederick Ketchum; Sterling C Johnson; Dorothy F Edwards; Cynthia M Carlsson; Walter Kukull; Sanjay Asthana Journal: Alzheimers Dement Date: 2019-10-07 Impact factor: 21.566
Authors: Sujuan Gao; Adesola Ogunniyi; Kathleen S Hall; Olusegun Baiyewu; Frederick W Unverzagt; Kathleen A Lane; Jill R Murrell; Oye Gureje; Ann M Hake; Hugh C Hendrie Journal: Alzheimers Dement Date: 2015-07-26 Impact factor: 21.566